Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Deferred Tax Liability: 2020-2024

Historic Non-Current Deferred Tax Liability for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Dec 2024 value amounting to $11,000.

  • Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability was N/A to $2.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $11,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability stood at $11,000, which was down 99.90% from $11.3 million recorded in FY2020.
  • Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability's 5-year high stood at $11.3 million during FY2020, with a 5-year trough of $11,000 in FY2024.
  • For the 1-year period, Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability averaged around $11,000, with its median value being $11,000 (2024).